# Diagnostic Device Risk Management of Atrial Fibrillation and Heart Failure

> **NCT01486316** · NA · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 24 (actual)

## Conditions studied

- Atrial Fibrillation
- Heart Failure

## Interventions

- **DEVICE:** Reveal XT® Insertable Cardiac Monitor
- **OTHER:** Heart Failure Risk Status Diagnostic

## Key facts

- **NCT ID:** NCT01486316
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01486316

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01486316, "Diagnostic Device Risk Management of Atrial Fibrillation and Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01486316. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*